X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (802) 802
index medicus (484) 484
oncology (382) 382
female (350) 350
hematology (339) 339
male (326) 326
middle aged (297) 297
adult (294) 294
randomized controlled trials as topic (251) 251
randomized-trial (213) 213
treatment outcome (212) 212
aged (173) 173
transplantation (172) 172
cancer (164) 164
adolescent (152) 152
antineoplastic agents - therapeutic use (129) 129
care and treatment (129) 129
bone-marrow-transplantation (128) 128
immunology (127) 127
chronic myelogenous leukemia (115) 115
chemotherapy (109) 109
randomized trial (106) 106
leukemia (105) 105
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (104) 104
research (104) 104
randomized controlled-trial (100) 100
risk factors (100) 100
medicine & public health (98) 98
therapy (94) 94
chronic myeloid-leukemia (93) 93
retrospective studies (91) 91
child (88) 88
animals (87) 87
transplantation, homologous (86) 86
stem-cell transplantation (85) 85
pharmacology & pharmacy (84) 84
imatinib mesylate (82) 82
survival (81) 81
health aspects (79) 79
protein kinase inhibitors - therapeutic use (79) 79
prognosis (78) 78
survival analysis (76) 76
stem cells (75) 75
antineoplastic combined chemotherapy protocols - therapeutic use (74) 74
young adult (74) 74
disease-free survival (73) 73
versus-host-disease (73) 73
hematology, oncology and palliative medicine (72) 72
chronic myeloid leukemia (71) 71
clinical trials (69) 69
clinical trials as topic (68) 68
hematopoietic stem cells (68) 68
survival rate (65) 65
acute myeloid-leukemia (64) 64
imatinib (64) 64
pyrimidines - therapeutic use (64) 64
follow-up studies (63) 63
analysis (62) 62
bone marrow transplantation (61) 61
hematopoietic stem cell transplantation - adverse effects (61) 61
acute lymphoblastic-leukemia (58) 58
benzamides (58) 58
drug therapy (58) 58
hematopoietic stem cell transplantation (58) 58
follow-up (56) 56
graft vs host disease - prevention & control (56) 56
bone-marrow transplantation (55) 55
transplantation conditioning - methods (55) 55
article (54) 54
child, preschool (53) 53
leukemia, myelogenous, chronic, bcr-abl positive - mortality (53) 53
neoplasms - drug therapy (53) 53
piperazines - therapeutic use (53) 53
dasatinib (52) 52
antineoplastic agents - administration & dosage (51) 51
antineoplastic agents - adverse effects (51) 51
mortality (51) 51
hematopoietic stem cell transplantation - methods (50) 50
total-body irradiation (50) 50
prospective studies (49) 49
aged, 80 and over (47) 47
recurrence (47) 47
stem cell transplantation (46) 46
acute disease (45) 45
leukemia, myelogenous, chronic, bcr-abl positive - therapy (45) 45
patients (45) 45
surgery (45) 45
bone marrow (44) 44
immunotherapy (44) 44
cell lung-cancer (41) 41
combined modality therapy (41) 41
hematologic neoplasms - therapy (41) 41
incidence (41) 41
prevention (41) 41
randomized phase-ii (41) 41
colony-stimulating factor (40) 40
graft vs host disease - etiology (40) 40
internal medicine (40) 40
time factors (40) 40
immunosuppressive agents - therapeutic use (39) 39
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 12/2011, Volume 118, Issue 26, pp. 6760 - 6768
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 11/2018, Volume 2018, Issue 1, pp. 161 - 167
June 2018 was the 20th anniversary of the clinical use of the first tyrosine kinase inhibitor (TKI), imatinib, for chronic myeloid leukemia. Since then, the... 
EARLY MOLECULAR RESPONSE | IMPACT | CHRONIC-PHASE | RANDOMIZED CML | FOLLOW-UP | TRANSCRIPT | DASATINIB | HEMATOLOGY | EDUCATION, SCIENTIFIC DISCIPLINES | INTERIM ANALYSIS | CHRONIC MYELOID-LEUKEMIA | FRONTLINE NILOTINIB | With Great Success Comes Great Responsibility | Chronic Myeloid Leukemia
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue 20, pp. 2125 - 2133
With the advent of tyrosine kinase inhibitors (TKIs), the goals of therapy in chronic myeloid leukemia (CML) are steadily shifting. Long-term disease control... 
TYROSINE KINASE INHIBITORS | CHRONIC MYELOGENOUS LEUKEMIA | TREATMENT-FREE REMISSION | TREATMENT DISCONTINUATION | CHRONIC-PHASE | RANDOMIZED CML | HARMONIZING CURRENT METHODOLOGY | DOMAIN MUTATIONS | HEMATOLOGY | CHRONIC MYELOID-LEUKEMIA | BCR-ABL TRANSCRIPTS
Journal Article
Leukemia, ISSN 0887-6924, 06/2016, Volume 30, Issue 6, pp. 1255 - 1262
Journal Article
Journal Article
Annals of Hematology, ISSN 0939-5555, 12/2015, Volume 94, Issue 12, pp. 2015 - 2024
Journal Article
Hematology. American Society of Hematology. Education Program, ISSN 1520-4391, 11/2018, Volume 2018, Issue 1, pp. 168 - 176
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2015, Volume 10, Issue 6, p. e0129648
Unbalanced (major route) additional cytogenetic aberrations (ACA) at diagnosis of chronic myeloid leukemia (CML) indicate an increased risk of progression and... 
CHRONIC MYELOGENOUS LEUKEMIA | TYROSINE KINASE INHIBITORS | RANDOMIZED CML | MULTIDISCIPLINARY SCIENCES | PHASE CML | EXPRESSION LEVELS | CENTROSOME ABERRATIONS | HUMAN CANCERS | CELL-LINE | CHRONIC MYELOID-LEUKEMIA | CHROMOSOMAL INSTABILITY | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - enzymology | Blast Crisis - pathology | Humans | Middle Aged | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Antineoplastic Agents - therapeutic use | Blast Crisis - enzymology | Young Adult | Fusion Proteins, bcr-abl - genetics | Imatinib Mesylate - therapeutic use | Proteolysis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Adolescent | Chromosome Aberrations | Aged, 80 and over | Cell Line, Tumor | Adult | Aged | Blast Crisis - genetics | Separase - metabolism | Chromosome Breakage | Clonal Evolution | Cysteine | Explosions | BCR protein | Therapy | Biotechnology | Mitosis | Hyperactivity | Leukemia | Aneuploidy | Kinases | Mimicry | Proteins | Protein folding | Cell cycle | Evolution | Blast crisis | Fusion protein | Imatinib | Separase | Myeloid leukemia | Abl protein | Chronic myeloid leukemia | Gene expression | Patients | Philadelphia chromosome | Endopeptidase | Medical prognosis | Cell lines | Mutation | Spindles | Cancer
Journal Article